LAB
Standard BioTools Inc.
Medical Devices · Healthcare · United States
0.62
close · 2026-10-29
value
91
cheaper than peers91
quality
35
stronger fundamentals35
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| EV to EBITDA | 3.67× | 99 |
| price to book | 0.45× | 98 |
| price to sales | 3.10× | 47 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 5.2% | 87 |
| return on equity | -11.2% | 56 |
| operating margin | -38.9% | 27 |
| revenue growth | -7.6% | 10 |
4 of 4 measures available
Facts
| market cap | $245M |
| free cash flow | $176.6M |
| employees | 385 |
| first trade | 2011-02-10 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-21 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.20 | -0.52 | -0.94 | -2.43 |
| free cash flow | -$82.6M | -$151.8M | -$46.1M | -$93.2M |
| net income | -$74.9M | -$138.9M | -$74.7M | -$190.1M |
| revenue | $85.3M | $91.0M | $106.3M | $97.9M |
| unusual items | -$16.9M | -$15.3M | -$13.6M | -$73.7M |